Found: 97
Select item for more details and to access through your institution.
Reduced‐intensity conditioning with fludarabine/busulfan versus fludarabine/low‐dose melphalan in patients with non‐Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1097, doi. 10.1111/bjh.19651
- By:
- Publication type:
- Article
Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 806, doi. 10.1002/ajh.27237
- By:
- Publication type:
- Article
Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph<sup>+</sup>ALL: A retrospective nationwide study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1606, doi. 10.1002/ajh.27041
- By:
- Publication type:
- Article
Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre‐transplant conditioning using fludarabine, reduced‐dose cyclophosphamide, and low‐dose thymoglobulin: A KSGCT prospective study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 251, doi. 10.1002/ajh.25693
- By:
- Publication type:
- Article
Different impact of BCR‐ABL transcripts on allogeneic hematopoietic cell transplantation from different graft sources for Ph + ALL with minimal residual disease.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 11, p. E301, doi. 10.1002/ajh.25612
- By:
- Publication type:
- Article
Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 47, doi. 10.1002/ajh.24933
- By:
- Publication type:
- Article
The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 2, p. 132, doi. 10.1002/ajh.23897
- By:
- Publication type:
- Article
In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 4, p. 294, doi. 10.1002/ajh.23392
- By:
- Publication type:
- Article
Dosimetric evaluation of ovaries and pelvic bones associated with clinical outcomes in patients receiving total body irradiation with ovarian shielding.
- Published in:
- Journal of Radiation Research, 2021, v. 62, n. 5, p. 918, doi. 10.1093/jrr/rrab066
- By:
- Publication type:
- Article
Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantation.
- Published in:
- Journal of Gastroenterology, 2022, v. 57, n. 8, p. 571, doi. 10.1007/s00535-022-01881-9
- By:
- Publication type:
- Article
Dosimetric Evaluation of the Uterus in Patients Receiving Total Body Irradiation with Ovarian Shielding.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Successful Treatment of the TEMPI Syndrome with Pomalidomide Plus Dexamethasone Followed by Autologous Stem Cell Transplantation.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 553, doi. 10.1159/000525056
- By:
- Publication type:
- Article
Neutropenia in the First Cycle of Consolidation Chemotherapy with High-Dose Cytarabine Is Not Associated with the Incidence of Relapse in Adult Acute Myeloid Leukemia Patients in First Complete Remission.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 4, p. 404, doi. 10.1159/000522037
- By:
- Publication type:
- Article
Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 3, p. 167, doi. 10.1002/ajh.21355
- By:
- Publication type:
- Article
Conventional allogeneic hematopoietic stem cell transplantation for lymphoma may overcome the poor prognosis associated with a positive FDG-PET scan before transplantation.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 6, p. 477, doi. 10.1002/ajh.21158
- By:
- Publication type:
- Article
Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 6, p. 472, doi. 10.1002/ajh.21152
- By:
- Publication type:
- Article
Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 3, p. 247, doi. 10.1002/ajh.21086
- By:
- Publication type:
- Article
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 10, p. 937, doi. 10.1002/ajh.20943
- By:
- Publication type:
- Article
Early relapse of JAK2 V617F-positive chronic neutrophilic leukemia with central nervous system infiltration after unrelated bone marrow transplantation.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 5, p. 386, doi. 10.1002/ajh.20805
- By:
- Publication type:
- Article
Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation.
- Published in:
- Clinical Transplantation, 2016, v. 30, n. 6, p. 703, doi. 10.1111/ctr.12737
- By:
- Publication type:
- Article
The safety and efficacy of acute graft-versus-host disease prophylaxis with a higher target blood concentration of cyclosporine around 500 ng/mL.
- Published in:
- Clinical Transplantation, 2013, v. 27, n. 5, p. 749, doi. 10.1111/ctr.12213
- By:
- Publication type:
- Article
Haploidentical transplantation using low‐dose alemtuzumab: Comparison with haploidentical transplantation using low‐dose thymoglobulin.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 3, p. 256, doi. 10.1111/ejh.13204
- By:
- Publication type:
- Article
Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched-pair analysis.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 5, p. 455, doi. 10.1111/ejh.12516
- By:
- Publication type:
- Article
Persistent Expression of Recipient-type ABH Antigen after ABO-incompatible Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Internal Medicine, 2022, v. 61, n. 12, p. 1887, doi. 10.2169/internalmedicine.8315-21
- By:
- Publication type:
- Article
Increased CD83 expression of CD34-positive monocytes in donors during peripheral blood stem cell mobilization in humans.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-53020-9
- By:
- Publication type:
- Article
Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantation.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 450, doi. 10.1007/s12185-023-03645-4
- By:
- Publication type:
- Article
Plasma ubiquitin C-terminal hydrolase-L1 (UCH-L1) level as a blood biomarker of neurological damage after allogeneic hematopoietic cell transplantation.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 3, p. 340, doi. 10.1007/s12185-023-03642-7
- By:
- Publication type:
- Article
Prophylactic or pre-emptive therapies to prevent relapse after allogeneic hematopoietic stem cell transplantation.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Different effects of thymoglobulin on acute leukemia with pre-transplant residual blasts in HLA mismatch transplantation.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 6, p. 889, doi. 10.1007/s12185-023-03563-5
- By:
- Publication type:
- Article
Decision analysis of allogeneic bone marrow transplantation versus immunosuppressive therapy for young adult patients with aplastic anemia.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 5, p. 660, doi. 10.1007/s12185-022-03530-6
- By:
- Publication type:
- Article
Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 3, p. 356, doi. 10.1007/s12185-022-03487-6
- By:
- Publication type:
- Article
Very early death within 30 days after diagnosis in patients with acute myeloid leukemia.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 2, p. 198, doi. 10.1007/s12185-022-03482-x
- By:
- Publication type:
- Article
Propensity score matching/reweighting analysis comparing autologous and allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 393, doi. 10.1007/s12185-022-03368-y
- By:
- Publication type:
- Article
NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 2, p. 199, doi. 10.1007/s12185-022-03328-6
- By:
- Publication type:
- Article
Comparison of the impact of two post-remission therapy regimens on cardiac events in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 2, p. 239, doi. 10.1007/s12185-022-03343-7
- By:
- Publication type:
- Article
Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCT.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 5, p. 748, doi. 10.1007/s12185-021-03284-7
- By:
- Publication type:
- Article
Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitors.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy.
- Published in:
- International Journal of Hematology, 2021, v. 114, n. 5, p. 608, doi. 10.1007/s12185-021-03198-4
- By:
- Publication type:
- Article
Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 6, p. 832, doi. 10.1007/s12185-021-03094-x
- By:
- Publication type:
- Article
Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical course of patients with aplastic anemia or myelodysplastic syndrome associated with persistent neutropenia.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 2, p. 82, doi. 10.1002/hon.1001
- By:
- Publication type:
- Article
FAME, a novel conditioning regimen for allogeneic stem cell transplantation for lymphoma, does not earn fame.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 1, p. 50, doi. 10.1002/hon.998
- By:
- Publication type:
- Article
False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 61, n. 2, p. 411
- By:
- Publication type:
- Article
Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy‐refractory or relapsed disease prior to allogeneic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 2, p. 403, doi. 10.1111/bjh.17646
- By:
- Publication type:
- Article
Impact of graft‐versus‐host disease and graft‐versus‐leukemia effect based on minimal residual disease in Philadelphia chromosome‐positive acute lymphoblastic leukemia.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 1, p. 84, doi. 10.1111/bjh.16540
- By:
- Publication type:
- Article
Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 1, p. 95, doi. 10.1111/bjh.12225
- By:
- Publication type:
- Article
Association between the kinetics of cytomegalovirus reactivation in terms of the area under the curve of cytomegalovirus antigenemia and non‐relapse mortality after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 5, p. 1, doi. 10.1111/tid.13715
- By:
- Publication type:
- Article
Association of the areas over and under the lymphocyte curve with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 1, p. 1, doi. 10.1111/tid.13460
- By:
- Publication type:
- Article
Impact of neutropenia evaluated in terms of the D‐index on invasive fungal disease while on empiric or preemptive antifungal treatment strategy in the early phase after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Transplant Infectious Disease, 2020, v. 22, n. 6, p. 1, doi. 10.1111/tid.13409
- By:
- Publication type:
- Article
Association between the kinetics of cytomegalovirus reactivation evaluated in terms of the area under the curve of cytomegalovirus antigenemia and invasive mold infection during the post‐engraftment phase after allogeneic hematopoietic stem cell transplantation
- Published in:
- Transplant Infectious Disease, 2020, v. 22, n. 5, p. 1, doi. 10.1111/tid.13387
- By:
- Publication type:
- Article